Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.67 USD | -1.87% | -1.32% | -19.38% |
May. 23 | Transcript : Arrowhead Pharmaceuticals, Inc. - Special Call | |
May. 20 | Arrowhead Pharmaceuticals Lung Disease Treatment Study Shows Lower Serum sRAGE in Asthma Patients | MT |
Financials (USD)
Sales 2024 * | 111M | Sales 2025 * | 170M | Capitalization | 3.06B |
---|---|---|---|---|---|
Net income 2024 * | -362M | Net income 2025 * | -332M | EV / Sales 2024 * | 24.9 x |
Net cash position 2024 * | 305M | Net cash position 2025 * | 157M | EV / Sales 2025 * | 17.1 x |
P/E ratio 2024 * |
-7.83
x | P/E ratio 2025 * |
-8.85
x | Employees | 525 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.52% |
Latest transcript on Arrowhead Pharmaceuticals, Inc.
1 day | -1.87% | ||
1 week | -1.32% | ||
Current month | +9.06% | ||
1 month | +3.74% | ||
3 months | -21.92% | ||
6 months | -14.81% | ||
Current year | -19.38% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-11-30 | |
Director of Finance/CFO | 57 | 08-12-31 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 10-11-22 |
Michael Perry
BRD | Director/Board Member | 64 | 11-12-18 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.40% | 0 M€ | 0.00% | - | |
0.35% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 24.67 | -1.87% | 818,785 |
24-05-22 | 25.14 | +0.48% | 634,296 |
24-05-21 | 25.02 | +0.81% | 522,763 |
24-05-20 | 24.82 | +0.20% | 444,363 |
24-05-17 | 24.77 | -0.92% | 710,610 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.38% | 3.12B | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- ARWR Stock